You are here

Article info

Article menu
Download PDFPDF
Editorial commentary
First approved treatment in children with multiple sclerosis slows brain atrophy

Authors

  • Arman Eshaghi Queen Square Multiple Sclerosis Centre, UCL Institute of Neurology, University College London, London, UK Centre for Medical Image Computing (CMIC), Department of Computer Science, University College London, London, United Kingdom PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Arman Eshaghi, Queen Square Multiple Sclerosis Centre, Department of Neuroinflammation, UCL Queen Square Institute of Neurology, Faculty of Brain Sciences, University College London, London WC1B 5EH, UK; a.eshaghi{at}ucl.ac.uk
View Full Text

Citation

Eshaghi A
First approved treatment in children with multiple sclerosis slows brain atrophy
Journal of Neurology, Neurosurgery & Psychiatry 2020;91:454.

Publication history

  • Received November 27, 2019
  • Accepted December 2, 2019
  • First published March 4, 2020.
Online issue publication 
April 15, 2020

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ.